|
2007-02-28
2007-02-26
- TOP Classes of Biologics with 2006 Sales of US$ 63.8 bln
Sales of the major cancer antibodies grew by 57 % to US$ 10.6 bln in 2006. Cancer antibodies are challenging the still no. 1 selling class of erythropoietins with 2006 sales of US$ 11.9 bln, but the lowest growth rate (6.4 %)
2007-02-22
2007-02-21
- Schizophrenic genes identified
A joint U.S.-Japanese study suggests gene mutations governing a key brain enzyme make people susceptible to schizophrenia.
2007-02-14
2007-02-13
2007-02-08
2007-02-07
2007-02-05
|
|